FindTrial
Sign In

efficacy and safety comparison of Trevo and Solitaire thrombectomy in the treatment of acute anterior pulmonary occlusive stroke:A multi-center retrospective cohort study

efficacy and safety comparison of Trevo and Solitaire thrombectomy in the treatment of acute anterior pulmonary occlusive stroke:A multi-center retrospective cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018466
Enrollment
Unknown
Registered
2018-09-20
Start date
2018-09-30
Completion date
Unknown
Last updated
2018-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Group 1:solitaire stent
Group 2:trevo stent

Sponsors

Xinqiao Hospital, the Third Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) onset time = 24h; 2) computed tomography angiography (CTA) / magnetic resonance angiography (MRA) / digital subtraction angiography (DSA) confirmed as acute anterior vessel proximal occlusion; 3) All patients choose trevo or solitaire retrievable stent thrombectomy device for thrombectomy.

Exclusion criteria

Exclusion criteria: 1) Computed tomography (CT) to determine intracranial hemorrhage; 2) Alberta Stroke Plan Early Diagnostic Score (ASPCTS) <6 points; 3) Not suitable for CTA/MRA/DSA; 4) Not using Trevo Stent or Solitaire, The stent is subjected to thrombectomy;

Design outcomes

Primary

MeasureTime frame
mRS score;—

Countries

China

Contacts

Public ContactZili Gong
gzl_944@163.com+86 13038315588

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026